The therapeutic efficacy of agonistic analogs of LH-RH in men with advanced prostate cancer was first demonstrated in collaboration with George Tolls et al. in a clinical trial at the Royal Victoria Hospital in Montreal in 1980-198112. The gene discussed is GNRH1; the disease is prostate cancer.